SCHEMBL30965341

SCHEMBL30965341

Cc1ccc(C2C(=O)Nc3ccc(Cl)cc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.43
PGR P06401 2/20 0.43
TP53 P04637 3/20 0.39
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
CASP1 P29466 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
SLC8B1 Q6J4K2 1/20 0.39
TRPM5 Q9NZQ8 1/20 0.39
TGM2 P21980 1/20 0.39
CES1 P23141 1/20 0.39
CDYL2 Q8N8U2 1/20 0.39
CDYL Q9Y232 1/20 0.39
ATM Q13315 1/20 0.38
MDM2 Q00987 1/20 0.38
CACNB4 O00305 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29242301 1.00 BRD4 (0.43) BRD4PGRTP53MAPTTSHR
SCHEMBL29242543 0.88 TP53 (0.40) PGRTP53TRPM5CES1MDM2
SCHEMBL30965336 0.87 BRD4 (0.47) BRD4TP53MAPTMEN1KMT2A
SCHEMBL29242303 0.87 BRD4 (0.47) BRD4TP53MAPTMEN1KMT2A
SCHEMBL30965348 0.85 PGR (0.41) BRD4PGRTP53MAPTTSHR
SCHEMBL29242310 0.85 PGR (0.41) BRD4PGRTP53MAPTTSHR
SCHEMBL7463659 0.84 BRD4 (0.51) BRD4PGRTP53MAPTTSHR
SCHEMBL3968668 0.84 CDYL2 (0.49) BRD4PGRTP53MAPTCDYL2
SCHEMBL30965344 0.82 PGR (0.41) PGRTP53MAPTTSHRCYP1A2
SCHEMBL29242350 0.82 PGR (0.41) PGRTP53MAPTTSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221565-A 3-Aryl indol-2-one compound with anticancer activity and application thereof in preparation of medicines for treating cancers 常州大学 2024-06-21 CN disclosed